Exploring the Frontier of Psychedelic Therapy: Harvard-Affiliated Hospital's Trial with Psilocybin

The Chronic Magazine
By Hunter DublinNov 21, 2023, 12:59 pm183 pts
In a groundbreaking move, a Harvard-affiliated hospital, Dana-Farber Cancer Institute, is conducting a pioneering trial to explore the potential of psilocybin — the active component in magic mushrooms — in palliative care. This trial marks a significant milestone in psychedelic research, especially since…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Aurora Expands Patient Access to Medical Cannabis in Canada With Extended Compassionate Pricing Program 66

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations 44

Trulieve Opening 162nd Florida Medical Cannabis Dispensary in Oakland Park 43

US Lawmaker Who Lost Limbs in War Convinces House to Allow Veteran Access to Cannabis 36

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.